logo
Symbols
Symbols
Aime
Products
News
Markets
Watchlist
Brokers
logo

LTRN

Lantern Pharma·NASDAQ
--
--(--)
--
--(--)

LTRN Filings

2026-02-23 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-01-23 · Key Events
Form 8-K - Current report
2026-01-13 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-13 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-13 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-13 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-13 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-22 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-22 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-13 · Earnings Call
Lantern Pharma Inc. (LTRN) Q3 2025 Earnings Call Transcript
logoproduct
PRODUCTS
AimeNewswireScreenerSuper ChartsMagic Portfolio
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareers
CONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
aime